April 14, 2021 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Bio-Techne Announces Licensing of Proprietary Antibody to Xencor for Therapeutic Development

MINNEAPOLIS, April 14, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced a license agreement for use of a proprietary Bio-Techne antibody by Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, for its therapeutic development pipeline. Bio-Techne is a global life sciences company providing... Read more

April 14, 2021 Atomic Spectroscopy Chromatography Life Science Tools Liq. Handling & Robotics Mass Spectrometry Molecular Spectroscopy PR/Corporate

Agilent Named One of Singapore’s Best Employers

Company rises in rank from last year SINGAPORE, April 14, 2021  Agilent Technologies Inc. (NYSE: A) today announced that Agilent Singapore has been recognized as one of Singapore’s Best Employers in 2021 for the second year-in-a-row by The Straits Times, a leading Singapore-based newspaper. Specifically, Agilent is ranked among the top 100 companies and fifth out... Read more

April 14, 2021 M&A, Partnerships

Pressure BioSciences Finalizes Plan to Acquire Global Eco-Friendly Agrochemical Supplier

Company Expects Acquisition to be Accretive with Sustained Profitable Revenue Growth,Leveraging Market-Changing Synergy from PBI’s Ultra Shear Technology Nanoemulsions Platform SOUTH EASTON, MA / ACCESSWIRE / April 14, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to... Read more

April 13, 2021 Lab Top-10 Life Science Tools PAI Top-10 PR/Corporate

PerkinElmer Provides First Quarter Update and Schedules Earnings Call for Tuesday, May 4, 2021

 Company also announces appointment of Steve Willoughby as vice president, investor relations WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 13, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates reported and organic revenue growth of 98% and 90%, respectively, for the first quarter ended April 4, 2021. PerkinElmer’s... Read more

April 13, 2021 Lab Top-10 PAI Top-10 PR/Corporate

Bruker Announces First Quarter 2021 Preliminary Revenue

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2021 in a range of $549 – $554 million, representing reported revenue growth of approximately 30% to 31%, compared to the first quarter of 2020. Adjusting for the impact of foreign currency translation and acquisitions, Bruker estimates... Read more

April 13, 2021 PR/Corporate

Xylem To Release First Quarter 2021 Financial Results On May 4, 2021

RYE BROOK, N.Y.–(BUSINESS WIRE)–Apr. 13, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, will release its first quarter 2021 results at 6:55 a.m. (ET) on Tuesday, May 4, 2021. At 10:00 a.m. (ET), Xylem’s senior management team will host a conference call with investors.... Read more

April 13, 2021 Environ, Ag./Food & Bev Lab Top-10 PAI Top-10 PR/Corporate

Danaher Provides Update On First Quarter 2021 Financial Performance

WASHINGTON, April 13, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) announced today that it expects first quarter 2021 core revenue growth to be above the high-end of the Company’s previously communicated guidance range. For the quarter ended April 2, 2021, the Company expects revenue growth to be approximately 57.0% and non-GAAP core revenue growth... Read more

April 13, 2021 Acad, Gov/Utilities

FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications

●  Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatment Basel, 13 April 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental Biologics License Application for Xolair® (omalizumab) prefilled syringe for self-injection... Read more

April 13, 2021 Environ, Ag./Food & Bev PR/Corporate

CORRECTING and REPLACING Illumina Named One of Singapore’s Best Employers

SINGAPORE–(BUSINESS WIRE)–First paragraph, second sentence of release should read: Illumina was second in Health Care and Equipment Services and placed 27th on the overall list. The updated release reads: ILLUMINA NAMED ONE OF SINGAPORE’S BEST EMPLOYERS Continues regional expansion with a focus on employees Illumina, Inc., today announced, for the second consecutive year, Illumina is... Read more